Basic science for the clinician 49: Expanding the description of the rna universe

Journal of Clinical Rheumatology

Volumn 15, Issue 2, 2009, Pages 90-94

  Sigal, Leonard H ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE PROTEIN; BETA INTERFERON; COMPLEMENTARY RNA; DOUBLE STRANDED RNA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GENOMIC RNA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LIN28 PROTEIN; MESSENGER RNA; MICRORNA; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PIWI INTERACTING RNA; RIBOSOME RNA; RIBOZYME; RNA; RNA BINDING PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TRANSFER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; VIRUS RNA; DIAGNOSTIC AGENT;

AUBERGINE; B CELL LYMPHOMA; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; DNA TRANSCRIPTION; DRUG STABILITY; EMBRYONIC STEM CELL; GENE SILENCING; GENETIC REGULATION; GENETIC VARIABILITY; HEMATOLOGY; HEPATITIS C; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFECTION RESISTANCE; INFLAMMATORY DISEASE; LUNG NON SMALL CELL CANCER; MEDICAL PRACTICE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RIBOSWITCH; RNA ANALYSIS; RNA SPLICING; RNA STABILITY; SEPTIC SHOCK; VIRUS REPLICATION; ANIMAL; ARTICLE; BIOGENESIS; METABOLISM; PHYSIOLOGY;

ANIMALS; BIOGENESIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; RNA;

EID: 67449087697     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31819c3a49     Document Type: Review

References (55)

1. Anderson P. Post-translational control of cytokine production. Nat Immunol. 2008;9:353-359.
2. Baltimore D, Boldin MP, O'Connell RM, et al. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839-845.
3. Berkhout B, Jeang K-T. RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem. 2007;282:26641-26645.
4. Birchler JA, Kavi HH. Slicing and dicing for small RNAs. Science. 2008; 320:1023-1024.
5. Blakaj A, Lin H. Piecing together the mosaic of early mammalian development through microRNAs. 2008;283:9505-9508.
6. Blencowe BJ, Khanna M. RNA in control. Nature. 2007;447:391-393.
7. Breaker RB. Complex riboswitches. Science. 2008;319:1795-1791.
8. Buchan JR, Parker R. The two faces of miRNA. Science. 2007;318:1877-1878.
9. Calame K. MicroRNA-155 function in B cells. Immunity. 2007;27:825-827.
10. Chi J-T, Chang HY, Wang NN, et al. Genomewide view of gene silencing by small interfering RNAs. PNAS. 2003;100:6343-6346.
11. Chien KR. MicroRNAs and the tell-tale heart. Nature. 2007;447:389-390.
12. Chong MM, Rasmussen JP, Rudensky AY, et al. The RNAse III enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med. 2008;205:2005-2017. Erratum in: J Exp Med. 2008;205. Rundensky, Alexander Y [corrected to Rudensky, Alexander Y].
13. Couzin J. MicroRNAs make big impression in disease after disease. Science. 2008;319:1782-1784.
14. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122:6-7.
15. Croce CM. Oncogenes and cancer. New Engl J Med. 2008;358:502-511.
16. Czech MP. MicroRNAs as therapeutic targets. New Engl J Med. 2006;354: 1194-1195.
17. Davis BN, Hilyard AC, Lagna G, et al. SMAD proteins control DROSHA-mediated microRNA maturation. Nature. 2008;454:56-61.
18. Filipowicz W. RNAi: the nuts and bolts of the RISC machine. Cell. 2005; 122:17-20.
19. Fujita T. Sensing viral RNA amid your own. Science. 2006;314:935-936.
20. Gantier MP, Sadler AJ, Williams BR. Fine-tuning of the innate immune response by microRNAs. Immunol Cell Biol. 2007;85:458-462.
21. Grosshans H, Filipowicz W. The expanding world of small RNAs. Nature. 2008;451:414-416.
22. Haasnoot J, Westerhout EM, Berkhout B. RNA interference against viruses: strike and counterstrike. Nat Biotechnol. 2007;25:1435-1454.
23. Hobert O. Gene regulation by transcription factors and micro-RNAs. Science. 2008;319:1785-9.
24. Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequence and lung cancer survival. J Clin Invest. 2008;118:2600 -2608.
25. Johnson DL, Johnson SAS. RNA metabolism and oncogenesis. Science. 2008;320:461-462.
26. Kim VN. Sorting out small RNAs. Cell. 2008;133:25-26.
27. Kim DH, Rossi JJ. RNAi mechanisms and applications. Biotechniques. 2008;44:613-616.
28. Leung AKL, Sharp PA. Function and localization of microRNAs in mammalian cells. Cold Spring Harb Symp Quant Biol. 2006;71:29-38.
29. Lin H. piRNAs in the germ line. Science. 2007;316:397.
30. Lindsay MA. micro-RNAs and the immune response. Trends Immunol. 2008;29:343-351.
31. Liston A, Lu LF, O'Carroll D, et al. Dicer-dependent micro-RNA pathway safeguards regulatory T cell function. J Exp Med. 2008;205:1993-2004.
32. Lodish HF, Zhou B, Liu G, et al. Micromanagement of the immune system by micro-RNAs. Nat Rev Immunol. 2008;8:120-130.
33. McBride JL, Boudreau R, Harper SQ, et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. PNAS. 2008;105:5868-5873.
34. Mack GS. Micro-RNA gets down to business. Nat Biotechnol. 2007;6:631-638.
35. Mao CP, Lin YY, Hung CF, et al. Immunological research using RNA interference technology. Immunology. 2007;121:295-307.
36. Marsden PA. RNA interference as potential therapy - Not so fast. New Engl J Med. 2006;355:953-954.
37. Makeyev EV, Maniatis T. Multilevel regulation of gene expression by micro-RNAs. Science. 2008;319:1789-1790.
38. Meister G. miRNAs get an early start on translational silencing. Cell. 2007;131:25-28.
39. Meister G. RNA interference in the nucleus. Science. 2008;321:496-497.
40. Miska EA. Micro-RNAs- keeping cells in formation. Nat Cell Biol. 2008;10: 501-502.
41. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58:1284 -1292.
42. O'Connell, Rao DS, Chaudhuri AA, et al. Sustained expression of mi-croRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med. 2008;205:585-594.
43. Piccinilli JA. Toward understanding self-splicing. Science. 2008;320:56-57.
44. Prujin GJM. The RNA interference pathway: a new target for autoimmunity. Arthritis Res Ther. 2006;8:110.
45. Reichow S, Varani G. RNA switches function. Nature. 2006;441:1054-1055.
46. Seila AC, Sharp PA. Small RNAs tell big stories in Whistler. Nat Cell Biol. 2008;10:630-633.
47. Simard MJ, Hutvagner G. Poster: RNA Silencing. Science. 2005;309:1518.
48. Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell. 2005;122:9-12.
49. Stadler BM, Ruohola-Baker H. Small RNAs: keeping stem cells in line. Cell. 2008;132:563-566.
50. Teng G, Hakimpour P, Landgraf P, et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity. 2008;28:621-629.
51. Van Rij RP. Virus meets RNAi. Symposium on antiviral applications of RNA interference. EMBO Rep. 2008;9:725-729.
52. van Rooj E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007;117:2369 -2376.
53. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: MicroRNAs can up-regulate translation. Science. 2007;318:1931-1934.
54. Wassenegger M. The role of the RNAi machinery in heterochromatin formation. Cell. 2005;122:13-16.
55. Zhou X, Jeker LT, Fife BT, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med. 2008;205:1983-1991.